Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Safety Syringes Market: By Product Type By Technology and Non-Retractable, By Therapy Type, and Geography
Safety Syringes Market size was valued at US$ 10.2 billion by 2023 and is poised to grow at a CAGR of 11.6% from 2024-2030. This report studies market dynamics elaborately to identify the current market trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. safety syringes industry report includes the competition analysis with a vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment hot spots) and market unmet needs. The market's key players include raw material suppliers, manufacturers, marketers, hospitals, physician offices, policymakers, and healthcare service providers who are engaged in the usage and advocacy of safe syringes.
Study Period
2024-2030Base Year
2023CAGR
11.6%Largest Market
EuropeFastest Growing Market
North America
Drivers: Governmental legislation propelling manufactures to develop syringes with safety mechanisms Restraints: High cost associated with safety syringes, Alternative drug delivery methods
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 10.2 billion |
Market CAGR |
11.6% |
By Product Type |
|
By Technology |
|
By Therapy Type |
|
Download Free Sample Report
The acupuncture market size was valued at US$ 10.2 billion in 2023
The safety syringes market key players are: Becton, Dickinson & Company (U.S.) Medtronic (U.S.) Revolutions Medical Corporation (U.S.) Retractable Technologies, Inc. (U.S.) Royal Imtech N.V. (Smiths Medical) (Netherlands Terumo Corporation (Japan) Unilife Corporation (U.S.) Sol-Millennium Medical Group (China) Ultimed, Inc. (U.S.) Axel Bio Corporation (U.S.)
The safety syringes market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Safety Syringes Market Introduction |
2.1. Global Safety Syringes Market - Taxonomy |
2.2. Global Safety Syringes Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Technology |
2.2.3. By Therapy Type |
2.2.4. Region |
3. Global Safety Syringes Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Key Developments |
4. Global Safety Syringes Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
4.1. Attached Needle |
4.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.3. Market Opportunity Analysis |
4.2. Detachable Needles |
4.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.2.3. Market Opportunity Analysis |
5. Global Safety Syringes Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Retractable |
5.1.1. Automatic |
5.1.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Manual |
5.1.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.2. Non-Retractable |
5.2.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.2.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3.3. Market Opportunity Analysis |
6. Global Safety Syringes Market By Therapy Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Insulin |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. GLP-1 |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Tuberculosis |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Growth Hormone |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Other |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Safety Syringes Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Safety Syringes Market - Opportunity Analysis Index, By Technology, Product Type, Therapy Type and Region, 2024 - 2030 |
8. North America Safety Syringes Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Attached Needle |
8.1.2. Detachable Needles |
8.2. Technology Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Retractable |
8.2.1.1. Automatic |
8.2.1.2. Manual |
8.2.2. Non-Retractable |
8.3. Therapy Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1. Insulin |
8.3.2. GLP-1 |
8.3.3. Tuberculosis |
8.3.4. Growth Hormone |
8.3.5. Other |
8.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.4.1. USA |
8.4.2. Canada |
9. Europe Safety Syringes Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Attached Needle |
9.1.2. Detachable Needles |
9.2. Technology Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Retractable |
9.2.1.1. Automatic |
9.2.1.2. Manual |
9.2.2. Non-Retractable |
9.3. Therapy Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1. Insulin |
9.3.2. GLP-1 |
9.3.3. Tuberculosis |
9.3.4. Growth Hormone |
9.3.5. Other |
9.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1. Germany |
9.4.2. France |
9.4.3. Italy |
9.4.4. Spain |
9.4.5. UK |
9.4.6. Rest of Europe |
10. Asia Pacific Safety Syringes Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Attached Needle |
10.1.2. Detachable Needles |
10.2. Technology Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Retractable |
10.2.1.1. Automatic |
10.2.1.2. Manual |
10.2.2. Non-Retractable |
10.3. Therapy Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Insulin |
10.3.2. GLP-1 |
10.3.3. Tuberculosis |
10.3.4. Growth Hormone |
10.3.5. Other |
10.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1. China |
10.4.2. Japan |
10.4.3. South Korea |
10.4.4. India |
10.4.5. Rest of APAC |
11. Latin America Safety Syringes Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Attached Needle |
11.1.2. Detachable Needles |
11.2. Technology Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Retractable |
11.2.1.1. Automatic |
11.2.1.2. Manual |
11.2.2. Non-Retractable |
11.3. Therapy Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Insulin |
11.3.2. GLP-1 |
11.3.3. Tuberculosis |
11.3.4. Growth Hormone |
11.3.5. Other |
11.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Brazil |
11.4.2. Mexico |
11.4.3. Argentina |
11.4.4. Rest of Latin America |
12. MEA Safety Syringes Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Attached Needle |
12.1.2. Detachable Needles |
12.2. Technology Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Retractable |
12.2.1.1. Automatic |
12.2.1.2. Manual |
12.2.2. Non-Retractable |
12.3. Therapy Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Insulin |
12.3.2. GLP-1 |
12.3.3. Tuberculosis |
12.3.4. Growth Hormone |
12.3.5. Other |
12.4. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1. GCC Countries |
12.4.2. South Africa |
12.4.3. Rest of MEA |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Becton, Dickinson & Company (U.S.) |
13.2.2. Medtronic (U.S.) |
13.2.3. Revolutions Medical Corporation (U.S.) |
13.2.4. Retractable Technologies, Inc. (U.S.) |
13.2.5. Royal Imtech N.V. (Smiths Medical) (Netherlands |
13.2.6. Terumo Corporation (Japan) |
13.2.7. Unilife Corporation (U.S.) |
13.2.8. Sol-Millennium Medical Group (China) |
13.2.9. Ultimed, Inc. (U.S.) |
13.2.10. Axel Bio Corporation (U.S.) |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Key Market Players